Thermo Fisher Scientific Inc.
TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3025% above fair value
$682.65−14.35 (-2.06%)
Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%
Thermo Fisher Scientific Adjusted EBITDA: $11,159M in FY2025, up 2.7% from a year earlier.
Latest, FY2025
11,159
Period ended Dec 31, 2025
Change on a year earlier
+2.7%
10,863 in FY2024
History
5 years
Since FY2021
Sources
3
Documents cited below
Where the FY2025 figure comes from
“Adjusted EBITDA (non-GAAP measure) $ 10,878 $ 10,863 $ 11,159”
Source: Q3 2026 Reconciliation of Financial Information ↗
Reported in IR Financial Reconciliation Package (Reconciliation of Adjusted EBITDA).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Adjusted EBITDA ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11,159 | +2.7% | Q3 2026 Reconciliation of Financial Information ↗ |
| FY2024 | Dec 31, 2024 | 10,863 | -0.1% | Q3 2026 Reconciliation of Financial Information ↗ |
| FY2023 | Dec 31, 2023 | 10,878 | -9.1% | Q3 2026 Reconciliation of Financial Information ↗ |
| FY2022 | Dec 31, 2022 | 11,971 | -7.7% | Q4 & FY2025 Reconciliation of Financial Information ↗ |
| FY2021 | Dec 31, 2021 | 12,969 | – | Q4 & FY2024 Reconciliation of Financial Information ↗ |
Cite this data
StockData. (2026). Thermo Fisher Scientific Adjusted EBITDA ($M), annual FY2021–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/adj-ebitda-m
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.